209 related articles for article (PubMed ID: 35429970)
41. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma.
Jiang C; Liu Y; Wen S; Xu C; Gu L
Pharmacol Res; 2021 Jul; 169():105644. PubMed ID: 33940186
[TBL] [Abstract][Full Text] [Related]
42. Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis.
Lei X; Zhang M; Guan B; Chen Q; Dong Z; Wang C
Hum Genomics; 2021 Jun; 15(1):39. PubMed ID: 34187556
[TBL] [Abstract][Full Text] [Related]
43. Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular Carcinoma.
Zhou Y; Wang L; Zhang W; Ma J; Zhang Z; Yang M; Yu J; Luo J; Yan Z
Dis Markers; 2022; 2022():6335155. PubMed ID: 35111268
[TBL] [Abstract][Full Text] [Related]
44. LINC01094 Predicts Poor Prognosis in Patients With Gastric Cancer and is Correlated With EMT and Macrophage Infiltration.
Ye Y; Ge O; Zang C; Yu L; Eucker J; Chen Y
Technol Cancer Res Treat; 2022; 21():15330338221080977. PubMed ID: 35254147
[No Abstract] [Full Text] [Related]
45. TMPRSS4 is a novel biomarker and correlated with immune infiltration in thyroid carcinoma.
Xu X; Sun T; Jing J
BMC Endocr Disord; 2022 Nov; 22(1):280. PubMed ID: 36380313
[TBL] [Abstract][Full Text] [Related]
46. Cancer Stemness, Immune Cells, and Epithelial-Mesenchymal Transition Cooperatively Predict Prognosis in Colorectal Carcinoma.
Xu F; Li S; Zhang J; Wang L; Wu X; Wang J; Huang Q; Lai M
Clin Colorectal Cancer; 2018 Sep; 17(3):e579-e592. PubMed ID: 29921496
[TBL] [Abstract][Full Text] [Related]
47. Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer.
Zhou Z; Xie X; Wang X; Zhang X; Li W; Sun T; Cai Y; Wu J; Dang C; Zhang H
Front Genet; 2021; 12():623424. PubMed ID: 33664769
[TBL] [Abstract][Full Text] [Related]
48. The transcriptome signature analysis of the epithelial-mesenchymal transition and immune cell infiltration in colon adenocarcinoma.
Heryanto YD; Imoto S
Sci Rep; 2023 Oct; 13(1):18383. PubMed ID: 37884639
[TBL] [Abstract][Full Text] [Related]
49. Adenovirus-mediated P311 inhibits TGF-β1-induced epithelial-mesenchymal transition in NRK-52E cells via TGF-β1-Smad-ILK pathway.
Qi F; Cai P; Liu X; Peng M; Si G
Biosci Trends; 2015 Oct; 9(5):299-306. PubMed ID: 26559022
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of integrin-linked kinase (ILK) promotes migration and invasion of colorectal cancer cells by inducing epithelial-mesenchymal transition via NF-κB signaling.
Yan Z; Yin H; Wang R; Wu D; Sun W; Liu B; Su Q
Acta Histochem; 2014 Apr; 116(3):527-33. PubMed ID: 24360977
[TBL] [Abstract][Full Text] [Related]
51. Shenqi detoxification granule combined with P311 inhibits epithelial-mesenchymal transition in renal fibrosis via TGF-β1-Smad-ILK pathway.
Cai P; Liu X; Xu Y; Qi F; Si G
Biosci Trends; 2017; 11(6):640-650. PubMed ID: 29311449
[TBL] [Abstract][Full Text] [Related]
52. Expression of integrin-linked kinase in adenoid cystic carcinoma of salivary glands correlates with epithelial-mesenchymal transition markers and tumor progression.
Zhao D; Yang K; Tang XF; Lin NN; Liu JY
Med Oncol; 2013; 30(3):619. PubMed ID: 23729269
[TBL] [Abstract][Full Text] [Related]
53. Identification of Hub Genes Associated With Immune Infiltration and Predict Prognosis in Hepatocellular Carcinoma via Bioinformatics Approaches.
Chen H; Wu J; Lu L; Hu Z; Li X; Huang L; Zhang X; Chen M; Qin X; Xie L
Front Genet; 2020; 11():575762. PubMed ID: 33505422
[TBL] [Abstract][Full Text] [Related]
54. A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
Xiong C; Wang G; Bai D
Bioengineered; 2020 Dec; 11(1):1034-1046. PubMed ID: 32951492
[TBL] [Abstract][Full Text] [Related]
55. [Expressions of CMTM8 and E-cadherin in primary and metastatic clear cell renal cell carcinoma].
Hu H; Chen JW; Xu KX; Wang D; Wang Y; Wang GW; Zhang SY; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 45(4):537-41. PubMed ID: 23939157
[TBL] [Abstract][Full Text] [Related]
56. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
[TBL] [Abstract][Full Text] [Related]
57. DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer-A Study Based on TCGA Database.
Hu M; Gu J; Su W; Zhang Z; Zhu B; Wang Q; Xing C
Biomed Res Int; 2021; 2021():4896106. PubMed ID: 34888380
[TBL] [Abstract][Full Text] [Related]
58. Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment.
Zeng Q; Sun S; Li Y; Li X; Li Z; Liang H
Front Oncol; 2019; 9():1555. PubMed ID: 32117786
[No Abstract] [Full Text] [Related]
59. Identification of prognostic and therapeutic value of CC chemokines in Urothelial bladder cancer: evidence from comprehensive bioinformatic analysis.
Li Y; Chen X; Li D; Yang Z; Bai Y; Hu S; Liu Z; Gu J; Zhang X
BMC Urol; 2021 Dec; 21(1):173. PubMed ID: 34893045
[TBL] [Abstract][Full Text] [Related]
60. System analysis of
Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
